510(k) · Cleared
ClearedSpacer G Temporary Hip Prosthesis
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Exactech, Inc. · KWL Prosthesis, Hip, Hemi-, Femoral, Metal
Cleared on Jan 22, 2004 as substantially equivalent to K974807 (Osteonics Corp., 1998) after a 220-day review. Its family tree reaches back 1 generation to 1998. 32 later devices descend from it.
- Decided
- Jan 22, 2004
- Review
- 220 days
- Class
- Class II
- Product code
- KWL
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K974807 (1998). 32 later devices descend from it, 5 citing it directly.
- Root · 1 generation backK974807 Osteo Austin Moore Endoprosthesis SystemOsteonics Corp. · 1998
- This deviceK031841 Spacer G Temporary Hip ProsthesisExactech, Inc. · 2004
- Descendant · cites it directly · 30 of its ownK052990 Stageone Disposable Cement Spacer Mold for Temporary Hip Prosthesis…Biomet, Inc. · 2005 · Recalled
- Descendant · cites it directly · 20 of its ownK062273 Spacer-G Temporary Hip ProsthesisTecres S.P.A. · 2008
- Descendant · 2 generations on · 19 of its ownK101356 Spacer-G and Spacer-KTecres S.P.A. · 2011
- Descendant · 3 generations on · 16 of its ownK112470 2GC Hip/Knee Modular SpacerMandell Horwitz Consultants, LLC · 2012
- Descendant · 4 generations on · 5 of its ownK183017 Remedy Femoral Component 84mm, Remedy Stemmed Knee SpacerOsteoremedies, LLC · 2019
Showing 5 of 32 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 32 · See all- K052990Stageone Disposable Cement Spacer Mold for Temporary Hip Prosthesis with Reinforcement…Biomet, Inc. · 2005 · cites it directly30descendants
- K062273Spacer-G Temporary Hip ProsthesisTecres S.P.A. · 2008 · cites it directly20descendants
- K101356Spacer-G and Spacer-KTecres S.P.A. · 2011 · 2 generations on19descendants
- K1124702GC Hip/Knee Modular SpacerMandell Horwitz Consultants, LLC · 2012 · 3 generations on16descendants
- K183017Remedy Femoral Component 84mm, Remedy Stemmed Knee SpacerOsteoremedies, LLC · 2019 · 4 generations on5descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K974807 | Osteo Austin Moore Endoprosthesis System | Osteonics Corp. | 1998 | — |
| 0 (this device) | K031841 | Spacer G Temporary Hip Prosthesis | Exactech, Inc. | 2004 | — |
| +1 | K052990 | Stageone Disposable Cement Spacer Mold for Temporary Hip Prosthesis with… | Biomet, Inc. | 2005 | 5 |
| +1 | K062273 | Spacer-G Temporary Hip Prosthesis | Tecres S.P.A. | 2008 | — |
| +2 | K101356 | Spacer-G and Spacer-K | Tecres S.P.A. | 2011 | — |
| +3 | K112470 | 2GC Hip/Knee Modular Spacer | Mandell Horwitz Consultants, LLC | 2012 | — |
| +4 | K183017 | Remedy Femoral Component 84mm, Remedy Stemmed Knee Spacer | Osteoremedies, LLC | 2019 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2005 | 1 | 0 |
| 2008 | 2 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2014 | 1 | 0 |
| 2016 | 2 | 0 |
| 2018 | 1 | 0 |
| 2019 | 6 | 0 |
| 2020 | 2 | 0 |
| 2021 | 1 | 0 |
| 2022 | 3 | 0 |
| 2023 | 2 | 0 |
| 2024 | 3 | 0 |
| 2025 | 3 | 0 |
| 2026 | 3 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KWL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new KWL device
- #1 K253675 OsteoRemedies Hip Spacer Systemscore 16.0 · 9 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K974807 | Osteo Austin Moore Endoprosthesis SystemSummary page 2…s substantially equivalent to the "Osteo Austin Moore Endoprosthesis" (Osteonics Corporation). The "Osteo" device was cleared for marketing through premarket submission #K974807. Model Manufacturer 510(k) Number Osteo Austin Moore Osteonics… | 1998 |
What descends from it? (32)
See all 325 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K052990 | Stageone Disposable Cement Spacer Mold for Temporary Hip Prosthesis with Reinforcement… | 2005 | 30 |
| K062273 | Spacer-G Temporary Hip Prosthesis | 2008 | 20 |
| K080979 | Stageone Select Cement Spacer Molds for Temporary Hip Replacement | 2008 | 3 |
| K252326 | InterSpace GV Hip Spacer | 2025 | 0 |
| K192041 | G21 SpaceFlex Hip | 2019 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All KWL devicesKWL Prosthesis, Hip, Hemi-, Femoral, Metal: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · KWL
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · KWL
32in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · KWL
2in 2017
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · KWL
29in 2025
MAUDE reports naming product code KWL, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 36 | 11 |
| 2008 | 1 | — | 0 | 13 |
| 2009 | 0 | — | 2 | 21 |
| 2010 | 0 | — | 0 | 55 |
| 2011 | 2 | — | 0 | 51 |
| 2012 | 1 | — | 0 | 62 |
| 2013 | 0 | — | 0 | 89 |
| 2014 | 0 | — | 0 | 107 |
| 2015 | 1 | — | 1 | 223 |
| 2016 | 0 | — | 0 | 210 |
| 2017 | 0 | — | 2 | 347 |
| 2018 | 2 | — | 0 | 294 |
| 2019 | 1 | — | 0 | 415 |
| 2020 | 1 | — | 0 | 270 |
| 2021 | 0 | — | 0 | 107 |
| 2022 | 1 | — | 0 | 99 |
| 2023 | 0 | — | 0 | 48 |
| 2024 | 1 | — | 0 | 143 |
| 2025 | 3 | 32 | 0 | 29 |
| 2026 | 2 | — | 1 | — |
What is it indicated for?
Spacer-G is indicated for temporary use (maximum 180 days) as an adjunct to total hip replacement (THR) in patients undergoing a two-stage procedure due to a septic process.
The device is inserted into the femoral medullary canal and acetabular cavity following removal of the existing femoral and acetabular implants and debridement. The device is intended for use in conjunction with systemic antimicrobial antibiotic therapy (standard treatment approach to an infection).
Spacer-G is not intended for use for more than 180 days, at which time it must be explanted and a permanent device implanted or another appropriate treatment performed (e.g. resection arthroplasty, fusion etc.).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K031841 · printed Nov 6, 2026
Cite this page
510(k) Report. “K031841: Spacer G Temporary Hip Prosthesis.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031841
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026